These findings indicate ZMIZ2 plays a significant role in the malignant progression of lung cancer, consistent with the findings of previous studies on colon, triple-negative breast cancers, and hepatocellular carcinoma, underscoring the oncogenic role of ZMIZ2 across various malignancies [15–17]. Here, ZMIZ2 is linked to hepatocellular carcinoma.